MedPath

Imaging Assessment of Diastolic Function

Phase 2
Conditions
Congenital Heart Disease
Interventions
Procedure: Echocardiograph
Procedure: Magnetic Resonance Imaging (MRI)
Registration Number
NCT01668264
Lead Sponsor
The Hospital for Sick Children
Brief Summary

Diastolic function is poorly studied in children with congenital heart disease. This is mainly due to the lack of validated techniques. Cardiac MRI offers two advantages compared to echocardiography: 1. accurate measurements of ventricular volumes and mass; 2. tissue characterization. The main advantage of echocardiography is a better temporal resolution which allows the study of short events like early relaxation. Overall there is a lack of studies correlating different echocardiographic and MRI parameters of heart function in pediatric populations with congenital or acquired heart diseases. This study will address specific questions on specific groups of patients that might bring more insight into chamber interaction and cardiac function. This study hypothesizes the following:

* Atrial enlargement is a marker of chronic increase in filling pressures and 3D echo might be the best method for follow-up.

* Cardiac remodeling associated with chronic loading results in changes in diastolic properties related to changes in cardiac mass and volume. This is related to changes in cardiac mechanics influencing diastolic parameters. Especially the influence on twisting and untwisting will be studied.

* Regional myocardial fibrosis and scarring may account for regional systolic and diastolic dysfunction with possible prognostic impact

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • All patients with tetralogy of Fallot post repair, transposition of great arteries after arterial switch operation, aortic valvulopathy (aortic stenosis and aortic regurgitation), coarctation of the aorta and cardiomyopathy, who are planned to undergo a cardiac MRI will be eligible.
  • Informed consent
Exclusion Criteria
  • Lack of informed consent
  • Need for general anesthesia
  • Similar contraindications as for a clinical MRI study apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
EchocardiographEchocardiographSubjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.
Magnetic Resonance Imaging (MRI)EchocardiographSubjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.
Magnetic Resonance Imaging (MRI)Magnetic Resonance Imaging (MRI)Subjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.
EchocardiographMagnetic Resonance Imaging (MRI)Subjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.
Primary Outcome Measures
NameTimeMethod
Atrial VolumesDay 1

Measure right and left atrial volumes by 2D and 3D echo and correlate the different echocardiographic measurements with MRI. This will allow identifying the most accurate measurement which can be used in clinical practice.

Secondary Outcome Measures
NameTimeMethod
Assess Ventricular VolumesDay 1

Assess ventricular volumes and mass and calculate mass/volume ratio. Study the effect of ventricular remodeling on myocardial mechanics especially twisting and untwisting. Relate these changes to evaluation of diastolic function.

Myocardial ScarringDay 1

Assess the presence of myocardial scarring in specific populations with congenital heart disease and correlate the findings with regional and global systolic and diastolic dysfunction.

Trial Locations

Locations (1)

The Hospital for Sick Children

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath